beta-D-Xylopyranosyl-(1->5)-alpha-L-arabinofuranosyl-(1->3)-L-arabinose

Metabolite details

Identifier

RBNRMSRJWILJMU-UHFFFAOYSA-N

InChI Key

RBNRMSRJWILJMU-UHFFFAOYSA-N

IUPAC name

4-[3,4-dihydroxy-5-[(3,4,5-trihydroxyoxan-2-yl)oxymethyl]oxolan-2-yl]oxyoxane-2,3,5-triol

Preferred name

beta-D-Xylopyranosyl-(1->5)-alpha-L-arabinofuranosyl-(1->3)-L-arabinose

INN name

—

Synonym

—

ChEBI

CHEBI:167935

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolomic Insights into the Browning of the Peel of Bagging ‘Rui Xue’ Apple Fruit
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Non_Bagged_Fruits_vs_Bagged_Fruits_With_Browning
• G1_PBS_vs_G2_DSS
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD